Site icon pharmaceutical daily

Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor Conference

LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will participate in Craig-Hallum’s 18th Annual Institutional Investor Conference on Wednesday, June 2, 2021.

Each year, Craig-Hallum hosts a multi-industry investor conference in Minneapolis featuring over 150 public companies where institutional clients can meet formally with corporate management. This year’s conference will be virtual and consists of one-on-one conference calls of 30-minutes’ duration. Attendance is by invitation only. For more information about the conference or to inquire about scheduling a one-on-one meeting with Mr. O’Connor, please contact Hayden IR at slp@haydenir.com.

About Simulations Plus, Inc.

Serving clients worldwide for 25 years, Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With our subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | Read our Environmental, Social, and Governance (ESG) Report.

Contacts

Simulations Plus Investor Relations
Ms. Renee Bouche

(661) 723-7723

renee@simulations-plus.com

Hayden IR

Mr. Brian S. Siegel, IRC®, M.B.A.

(346) 396-8696

slp@haydenir.com

Exit mobile version